These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 729227)

  • 1. Effect of sex hormones on immunity.
    Ablin RJ
    Clin Oncol; 1978 Dec; 4(4):379-82. PubMed ID: 729227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further evaluation of the effect of estrogen on tumor-associated immunity in prostatic cancer.
    Ablin RJ; Bhatti RA; Guinan PD
    Isr J Med Sci; 1979 Jan; 15(1):9-11. PubMed ID: 422345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible suppression of host resistance by estrogen therapy for prostatic cancer.
    Ablin RJ
    Can Med Assoc J; 1976 Dec; 115(11):1082-4. PubMed ID: 1000436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The molecular mechanisms of the action of steroid hormones and the reasons for breast cancer resistance to hormonal therapy].
    Gnatyshak AI; Dryzhak VI
    Vopr Onkol; 1991; 37(2):131-6. PubMed ID: 2014691
    [No Abstract]   [Full Text] [Related]  

  • 5. Endocrine therapy of breast and prostate cancer.
    Manni A
    Endocrinol Metab Clin North Am; 1989 Jun; 18(2):569-92. PubMed ID: 2663486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of CEA and GCDFP-15 plasma level during hormonally induced cancer stimulation.
    Manni A; Santen RJ; Boucher AE; Lipton A; Harvey H; Drago J; Rohner T; Haagensen D; Glode M; Santner SJ
    Anticancer Res; 1984; 4(3):141-4. PubMed ID: 6380398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 17 beta-estradiol and medroxyprogesterone acetate upon MtTW15 mammosomatotropic pituitary tumor growth and hormone production in male and female rats.
    Winneker RC; Parsons JA
    Cancer Res; 1981 May; 41(5):1772-7. PubMed ID: 7214344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of prostate-specific antigen expression by synthetic progestins in patients with prostate and breast cancer.
    Diamandis EP
    Mayo Clin Proc; 1998 Jul; 73(7):706-7. PubMed ID: 9663206
    [No Abstract]   [Full Text] [Related]  

  • 9. Polyestradiol phosphate and ethinyl estradiol in treatment of prostatic carcinoma.
    Lindstedt E
    Scand J Urol Nephrol Suppl; 1980; 55():95-7. PubMed ID: 6938044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The modulators of the estrogenic activity].
    Kirkiacharian S
    Ann Pharm Fr; 2000 Dec; 58(6):383-91. PubMed ID: 11148373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal therapy and alterations of immunity in prostatic cancer.
    Ablin RJ
    Neoplasma; 1981; 28(3):345-50. PubMed ID: 7290262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thyroid hormones in metastasizing prostate cancer treated with polyestradiol phosphate].
    Dunzendorfer U; Schulz H
    Z Urol Nephrol; 1982 Jul; 75(7):493-500. PubMed ID: 6183845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Estrogen thearpy in practice. 3. Estrogen preparations and combination preparations].
    Lauritzen C
    Fortschr Med; 1977 Jun; 95(21):1388-92. PubMed ID: 559617
    [No Abstract]   [Full Text] [Related]  

  • 14. Estrogenic regulation of host immunity against an estrogen receptor-negative human breast cancer.
    Curran EM; Judy BM; Duru NA; Wang HQ; Vergara LA; Lubahn DB; Estes DM
    Clin Cancer Res; 2006 Oct; 12(19):5641-7. PubMed ID: 17000652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regucalcin is under-expressed in human breast and prostate cancers: Effect of sex steroid hormones.
    Maia C; Santos C; Schmitt F; Socorro S
    J Cell Biochem; 2009 Jul; 107(4):667-76. PubMed ID: 19347872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of cytomorphological parameters during hormonal therapy of prostatic carcinoma (author's transl)].
    Keller AJ; Völter D; Bertsch H
    Urologe A; 1981 Jul; 20(4):228-30. PubMed ID: 7196633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone therapy for cancer. II. Breast and prostate.
    Drug Ther Bull; 1970 Jul; 8(16):61-3. PubMed ID: 5453278
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of sex hormones on peripheral immunity in patients with advanced breast cancer.
    Franks CR; Williams Y
    Clin Oncol; 1978 Mar; 4(1):19-24. PubMed ID: 639376
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormonal therapy of cancer.
    Kelley RM
    Mod Treat; 1966 Jul; 3(4):766-90. PubMed ID: 5941803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.